Status:
UNKNOWN
Intravenous Lidocaine to Reduce ED50 for Propofol Administered Using Target Controlled Infusion (TCI) During Gastroscopy
Lead Sponsor:
Erasme University Hospital
Conditions:
Diagnostic Gastroscopy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The goal of this prospective, interventionnal clinical trial is to assess if intravenous administration of linisol reduce the ED50 of propofol when administered using Target Controlled Infusion (TCI) ...
Eligibility Criteria
Inclusion
- Patients scheduled for gastroscopy under narcosis and who have signed the consent.
- ASA score: 1 and 2
- BMI between 18 and 30 kg/m2
Exclusion
- Lidocaine allergy
- Anesthesia within the last 7 days
- Use of local anesthesia in the last 24 hours
- Rhythm disorder or HR \<50
- Pregnant women and breastfeeding
- Participation in another clinical study in the last months
- Cannot understand VAS score or French
- Severe central nervous disease and mental illness.
- Obstructive sleep apnea (known or STOP BANG score \>5)
- Upper lung infection.
- Liver or kidney function disorder
Key Trial Info
Start Date :
April 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06143410
Start Date
April 8 2024
End Date
August 31 2024
Last Update
April 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boudart Céline
Brussels, Belgium, 1070